Valora Therapeutics’ antibody lectin chimeras, or AbLecs, target glyco-immune checkpoints, pathways that modulate cellular communication with the immune system. The startup’s science is based on research from Carolyn Bertozzi, a Stanford professor who was awarded the 2022 Nobel Prize in Chemistry.
Startup TrX1 develops cell therapies that function like a particular type of regulatory T cell, or Treg, whose role includes dampening inflammation and inducing long-term tolerance. Based on research from Stanford, TrX1’s lead program is a potential therapy for preventing graft-versus-host disease.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
Atropos Health — a company that delivers clinical data to physicians at the point of care to help them treat complex patients — recently launched a clinical advisory board and new evidence network. Both announcements are meant to enhance the credibility and transparency of its physician consult platform, CEO Brigham Hyde said at ViVE in Nashville.
Cargo Therapeutics is developing CAR T-cell therapies that overcome ways cancers evade currently available treatments. True to its name, the startup’s approach involves putting more cargo and more complex cargo onto engineered T cells.
A study published in Circulation showed that the Apple Watch’s ECG detected some arrhythmias other than atrial fibrillation. The device is currently cleared to take ECGs and general irregular pulse alerts, which could indicate potential cases of atrial fibrillation.
Of 26 health systems surveyed by MedCity News, nearly half used automated tools to respond to the Covid-19 pandemic, but none of them were regulated. Even as some hospitals continued using these algorithms, experts cautioned against their use in high-stakes decisions.
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.
In a review of 130 FDA-cleared AI tools, researchers found that the vast majority of them relied on retrospective studies. Most of the developers also didn’t share information on how many sites the algorithms had been tested in, or how they performed in different patient demographics.
Experts differ on whether Apple's clinics are a threat to hospitals but agree that collaboration with employer clinics is key as is a commitment to outcomes and cost transparency.
Study participants are using VivaLNK's Vital Scout wearable patches as researchers examine whether there are associations between stress and depression in teenagers.
Stanford Children's Health CMIO Natalie Pageler described how the organization is doing everything from using VR to putting multiple screens in a patient room to cater to the needs of kids and their families.
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
The German life sciences company plans to bring its accelerator program for digital health startups to San Francisco. It's now available in Berlin, Moscow, and Shanghai among other places.
Certain opioids could be created using yeast instead of poppies. This raises concerns with the DEA and FBI, but so far it looks like it will be a while before this is even a real option in the lab for mass production.
Indianapolis-based SonarMed continues to move forward with perfecting and providing its non-invasive, adjunctive device that provides real-time monitoring of endotracheal tube position and function, originally developed at Purdue University by SonarMed founders Dr. Jeffrey Mansfield, Dr. Eduardo Juan, and Dr. George Wodicka.
Hospitals across the country continually deal with alarm fatigue, an issue borne out of well-meaning but ultimately misguided attempts to monitor patient safety, and the results of simply having too many alerts can, in the worst-case, be deadly or near deadly. At a minimum, the issue can significantly impact work flow at busy hospitals, prompting nurses […]
There have been literally thousands of tweets flying out of Stanford’s Med X conference, which isn’t really surprising considering the venue. Here’s just a small smattering. We live in a real, 3D, tactile world. A 2D screen is actually a frustrating barrier for some people. #MedX — Paul Grant (@paulgrant) September 5, 2014 “That is […]